A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

This study has been terminated.
(See termination reason in detailed description.)
Sponsor:
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00287066
First received: February 2, 2006
Last updated: February 20, 2008
Last verified: April 2007

February 2, 2006
February 20, 2008
February 2006
Not Provided
18F-labeled glucose uptake in muscle
Same as current
Complete list of historical versions of study NCT00287066 on ClinicalTrials.gov Archive Site
Glucose turnover overnight Insulin pharmacokinetics
Same as current
Not Provided
Not Provided
 
A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
Open-Label Randomized Two-Way Crossover Pilot Study To Estimate The Effects Of Inhaled Versus IV Infusion Of Human Insulin With Regards To Glucose Disposal In Subjects With Type 1 Diabetes Mellitus

To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes

The study was terminated on Oct. 28, 2007. The protocol was undergoing implementation and methodological issues with major revisions that qualified this trial as a new trial. Pfizer decided to cancel new trials because of the decision to withdraw Exubera due to lack of market performance and not for safety reasons.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Diabetes Mellitus
  • Drug: Inhaled Human Insulin
  • Drug: Regular Human Insulin
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
22
March 2007
Not Provided

Inclusion Criteria:

  • Diabetes mellitus Type 1

Exclusion Criteria:

  • Asthma, COPD
  • Smoking
Both
18 Years to 50 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00287066
A2171060
Not Provided
Not Provided
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
April 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP